Mitral Valve
2025-2026 [Sydney]
Medical Devices - Cardiovascular Prosthetics
“Mitral regurgitation is the most common valvular heart disease worldwide and is associated with substantial morbidity and mortality when left untreated.”
Douedi, S., & Alahmadi, M. H. (2026). Mitral regurgitation. In StatPearls [Internet]. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK507196/
The Sydney Heart Valve team worked to advance the treatment of mitral regurgitation through an innovative D-shaped tissue valve prosthetic. My contribution was to evolve the valve's stent design through eight iterations, each with distinct characteristics for rigorous durability testing of millions of cycles.
Each iteration incorporated insights from previous studies and hands-on feedback from cardiologists and heart surgeons.
The main challenge of this project was maintaining precision while working with minuscule dimensions and complex organic shapes designed to mimic the heart's existing valve geometry.
I collaborated with fellow designer Rennie Hsiao, who skillfully sutured tissue to the stents I developed, transforming them into testable prosthetics.
Want to see more?
Dashgrid
2022 [Montréal]
Office Furniture
Most work surfaces like tables, cutting boards, paper, and screens are limited to two dimensions. This project explores how a modular space divider with multi-axis functionality can expand the creative workspace, allowing workers to utilize vertical and spatial dimensions alongside traditional flat surfaces.
Dashgrid's modular design allows users to assemble it into any configuration needed. They can prioritize vertical surfaces for height, flat surfaces for storage, or a combination tailored to their specific workflow.
Dashgrid also disassembles into a compact, space-efficient format for easy shipping and storage.
Want to see more?
Mitral Valve
2025-2026 [Sydney]
Medical Devices - Cardiovascular Prosthetic
“Mitral regurgitation is the most common valvular heart disease worldwide and is associated with substantial morbidity and mortality when left untreated.”
Douedi, S., & Alahmadi, M. H. (2026). Mitral regurgitation. In StatPearls [Internet]. National Center for Biotechnology Information. https://www.ncbi.nlm.nih.gov/books/NBK507196/
The Sydney Heart Valve team worked to advance the treatment of mitral regurgitation through an innovative D-shaped tissue valve prosthetic. My contribution was to evolve the valve's stent design through eight iterations, each with distinct characteristics for rigorous durability testing of millions of cycles.
Each iteration incorporated insights from previous studies and hands-on feedback from cardiologists and heart surgeons.
The main challenge of this project was maintaining precision while working with minuscule dimensions and complex organic shapes designed to mimic the heart's existing valve geometry.
I collaborated with fellow designer Rennie Hsiao, who skillfully sutured tissue to the stents I developed, transforming them into testable prosthetics.